In adults and children, a rapid POC antigen test for COVID-19 (LumiraDx) had ≥97% sensitivity and specificity vs. RT-PCR.
Where this comes from
- Record sourced from PubMed, PMID 34224255.
- Also identified by DOI 10.7326/ACPJ202107200-082.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drain PK, Ampajwala M, Chappel C, et al. <b>A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care: a clinical performance study.</b> Infect Dis Ther. 2021;10:753-61 33629225.
Medical subject headings
- COVID-19